African Pharmaceutical Review.

African Pharmaceutical Review.

Pharverse
Trending
10 Important Medical Product Recalls In The African Market So Far (2024)
AstraZeneca to pay up to $1.92 billion for potentially new lipid lowering molecule
Cipla expands in South Africa with acquisition of Actor Pharma for $49million

R&D

View All
Disrupting and accelerating drug discovery for faster and more accurate lead identification

Disrupting and accelerating drug discovery for faster and more accurate lead identification

Research shows 2-drug HIV regimen with comparable efficacy to 3-drug regimen

Research shows 2-drug HIV regimen with comparable efficacy to 3-drug regimen

Novartis Kisqali® has received FDA approval to lower recurrence risk in patients with HR+/HER2-early breast cancer.

Novartis Kisqali® has received FDA approval to lower recurrence risk in patients with HR+/HER2-early breast cancer.

Bristol Myers Squibb’s Zeposia exhibits sustained safety and efficacy in Multiple sclerosis

Bristol Myers Squibb’s Zeposia exhibits sustained safety and efficacy in Multiple sclerosis

Roche’s Xofluza reduces transmission of flu viruses, global trial shows

Roche’s Xofluza reduces transmission of flu viruses, global trial shows

Novo Nordisk’s Wegovy® expects label update to include benefits in improving heart failure symptoms and physical function.

Novo Nordisk’s Wegovy® expects label update to include benefits in improving heart failure symptoms and physical function.

AstraZeneca’s Fasenra set to be approved for eosinophilic granulomatosis treatment.

AstraZeneca’s Fasenra set to be approved for eosinophilic granulomatosis treatment.

FDA approves drug with new pharmacological approach to schizophrenia treatment

FDA approves drug with new pharmacological approach to schizophrenia treatment

AstraZeneca to pay up to $1.92 billion for potentially new lipid lowering molecule

AstraZeneca to pay up to $1.92 billion for potentially new lipid lowering molecule